The recent controversy about the potential dangers of publishing scientific methodologies on the generation of variants of avian HIN1 influenza capable of infecting ferrets raises some interesting and relevant issues. One of the central issues is does the publication of such scientific data offer the potential for the production of a bioterrorism agent.
Influenza A virus is a serious human pathogen. The pandemic influenza outbreak in 1918 (“Spanish flu”) may have killed at least 50 million people worldwide.1 The WHO estimates that up to 50% of the world’s population became infected approximating to a mortality rate of 2–2.5%. In fact, this is almost definitively an underestimation and progressive studies tends to result in an upwards revision of mortality estimates. Poor record keeping, loss of data and probably, in some parts of the world, little documentation of cases account for the difficulty in establishing the total number of cases. Just how lethal the 1918 virus was can be put in context when compared with a death rate of approximately 100,000 cases for the combined 1957 and 1968 influenza pandemics. The 1918 flu pandemic came in three waves, the first wave occurred in the spring of 1918, the second wave in the autumn (September to November) and the third wave in the spring of 1919. The second wave was by far the most virulent and lethal and probably resulted from the virus acquiring mutations that dramatically improved its human to human transmission and pathogenic characteristics.
It has not been definitively established that the 1918 influenza pandemic virus was an avian virus that adapted to successfully infect humans or whether it may have originated from gene reassortment (antigenic shift) as was observed in the subsequent emergence of the 1957 (Asian flu) and 1968 (Hong Kong flu) flu pandemics.2 Evidence for the avian origins of the 1918 has been argued based on sequence analysis of amino acid variation in the polymerase proteins consistent with that of avian-derived virus sequences.3 The polymerase PB1 gene and the haemagglutinin gene in both the 1957 and 1968 pandemic viruses are also believed to be of avian origin, acquired by genetic reassortment. Troubling, perhaps, is the observation that many of the present circulating pathogenic H5N1 viruses are accumulating similar amino acid changes in the polymerase protein.
H5N1 viruses have been circulating in poultry certainly since 1996 and possibly for decades.4 Highly pathogenic strains of H5N1 virus have spread from Asia to Europe and Africa infecting millions of poultry and wild birds. In 1997 in China, a novel avian influenza virus, H5N1, capable of infecting humans emerged and has continued to cause human infection and death. Perhaps one of the prime concerns relating to the danger of H5N1 transmission and infection of humans is the widely published mortality rate of 50–60% among people infected with H5N1 (352 deaths in 598 cases).5 Many of these cases have occurred in developing countries and it is probable that subclinical and mild H5N1 illness has been under reported and documented. A recent serological meta-analysis study may be a better indicator, it estimates that the rate of infection of H5NI is approximately 1–2%, implying that millions of people may have been infected worldwide and indicating a much lower mortality rate.6
So how dangerous are the ferret transmission studies of Foucheir and Kawaoka? The authors apparently have introduced several mutations into the H5 gene of avian H5 viruses and can demonstrate successful aerosol transmission of H5 viruses in ferrets, a well recognized mammalian influenza A animal model. Ferrets are susceptible to infection but are more likely to suffer disseminated, multi-organ disease than humans and the mutations required for successful human transmission are likely to differ to some extent to that of ferrets.
In many ways a number of papers published over the last decade on the 1918 pandemic virus could be viewed as presenting much more significant biohazard potential. In 2005, the complete sequence of the 1918 H1N1 virus was published and methodologies describing how virus nucleic acid was recovered from paraffin-embedded autopsy tissue and from frozen lung tissue.3,7 The study successfully generated all 8 gene segments of the virus and by a process of reverse genetics produced progeny virus capable of infecting and inflicting high mortality rates in mice and high replication rates observed in human bronchial epithelial cells. This reverse genetic approach has been successfully applied to many viruses such as Hepatitis C and Norovirus so certainly the technology is out there in cyberspace. Mutations in haemagglutinin required for the successful binding of H5N1 virus to human sialic acid receptors have also been published.8 Human and avian influenza A viruses differ in virus receptor recognition, human viruses preferentially binding to sialic acid-α 2,6 galactose receptors and avian viruses to sialic acid-α 2,3 galactose receptors.8 An adaption to recognition of the 2,6 galactose receptor is believed to be a requirement for successful infection of human respiratory tract cells.
As scientists we do need to act in a responsible fashion irrespective of the fact that the tabloid press can often sensationalise certain scientific findings. In recent years people do appear to have become very cynical of many scientific advances, often preferring to choose to look at the potential negative impact of the discovery. Should we as scientists be concerned about the public perception of scientists and scientific experimentation? Public opinion can influence legislators who can in turn influence funding, particularly government funding, of research. A not insignificant number of people still believe that the HIV virus was generated by some sinister forces as a blight on mankind. They fail to be convinced that the virus is the progeny of a simian immunodeficiency virus likely to have evolved to infect humans sometime in the past 100 y. Indeed there are HIV seropositive blood samples identified as far back in 1957, only 4 y after the discovery of the structure of DNA and many years before the development of molecular biology techniques capable of genetically manipulating viral genomes.
The development of molecular biology methodologies during the 1960s and 1970s lead to the “Berg letter” and the subsequent Asilomar Conference in 1975 to examine the biohazard potential and draw up procedures for the safe handling of recombinant DNA molecules. This was an appropriate response by scientists to the emergence of a new technology with far reaching consequences.
Should we be performing science that is of a questionable nature? What are the pros and cons of genetically manipulating an avian influenza virus to more effectively infect mammalian species. When do the risks outweigh the benefits? The dangers associated with the inappropriate use of such information has been highlighted. Can the generation of H5N1 mutants and subsequent infectivity studies in ferrets greatly advance our knowledge and help predict likely H5N1 viruses capable of infecting humans? If so, this knowledge should guide us and emphasize the importance of epidemiological surveillance of emerging H5N1 strains that are naturally accumulating these mutations.
True, there are vaccines that protect against H5N1 and H1N1.The questions with influenza A vaccines are always, “Is there enough virus vaccine stockpiled to deal with a pandemic? How good is its shelf life over an extended period of time and, ultimately, the great unknown? Will it protect (totally or partially) against an avian strain that may naturally emerge to successfully infect humans?” Similar considerations can be applied to antivirals like oseltamivir. The incubation period for influenza A infection is short, the order of days, pandemics can be established in weeks.
In light of a number of existing publications on H1N1 and H5N1, it’s difficult to fully understand the hesitancy to publish the ferret H5N1 infection papers, but caution is never a bad thing. Let’s hope the issue can be resolved in a timely manner. The more likely event is that nature will out. Nature will dictate, by mutation and natural selection, whether some variant in the present pool of circulating avian H5N1 viruses acquires the ability to successfully infect humans, and will perform umpteen natural genetic engineering experiments. Let’s be steadfast in our monitoring and hope nature doesn’t get it right.
Footnotes
Previously published online: www.landesbioscience.com/journals/biobugs/article/20190
References
- 1.Johnson NP, Mueller J. Update the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76:105–15. doi: 10.1353/bhm.2002.0022. [DOI] [PubMed] [Google Scholar]
- 2.Tumpey TM, Belser JA. Resurrected pandemic influenza viruses. Annu Rev Microbiol. 2009;63:79–98. doi: 10.1146/annurev.micro.091208.073359. [DOI] [PubMed] [Google Scholar]
- 3.Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005;437:889–93. doi: 10.1038/nature04230. [DOI] [PubMed] [Google Scholar]
- 4.Martin V, Sims L, Lubroth J, Kahn S, Domenech J, Begnino C. History and evolution of HPAI viruses in southeast Asia. Ann N Y Acad Sci. 2006;1081:153–62. doi: 10.1196/annals.1373.017. [DOI] [PubMed] [Google Scholar]
- 5.WHO. Cumulative number of conformed human cases for avian influenza A(H5N1) reported to WHO, 2003-2012.
- 6.Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science. 2012;335:1463. doi: 10.1126/science.1218888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005;310:77–80. doi: 10.1126/science.1119392. [DOI] [PubMed] [Google Scholar]
- 8.Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006;444:378–82. doi: 10.1038/nature05264. [DOI] [PubMed] [Google Scholar]
